Horizon Therapeutics (HZNP 104.72, +25.96, +33.0%): received takeover interest from (AMGN, JNJ, SNY), according to The Wall Street Journal.
CrowdStrike (CRWD 113.28, -24.72, -17.9%): beats by $0.08, beats on revs but says that total net new ARR was below expectations; guides Q4 EPS above consensus, revs below consensus; downgraded to Hold from Buy at Stifel
Workday (WDAY 156.67, +13.37, +9.3%): beats by $0.15, reports revs in-line; raises FY23 subscription revenue guidance; approves new share repurchase program for up to $500 mln
Hewlett Packard Enterprise (HPE 15.75, +0.29, +1.9%): reports EPS in-line, beats on revs; guides JanQ EPS above consensus, revs above consensus; reaffirms FY22 EPS guidance
NetApp (NTAP 64.01, -7.78, -10.8%): beats by $0.15, reports revs in-line; guides Q3 EPS below consensus, revs below consensus; guides FY23 EPS in-line, revs below consensus
Hormel Foods (HRL 44.77, -3.42, -7.1%): beats by $0.01, misses on revs; guides FY23 EPS below consensus, revs below consensus
Intuit (INTU 378.99, -0.72, -0.2%): beats by $0.46, beats on revs; guides Q2 EPS and revs below consensus; reaffirms FY23 EPS guidance, guides FY23 revs below consensus; Credit Karma experienced continuing deterioration
Biogen (BIIB 299.92, +8.51, +2.9%): Eleven experts from leading medical institutions and eight experts from Eisai publish full results of Lecanemab Phase 3 confirmatory clarity ad study for early Alzheimer's disease in the New England Journal of Medicine
Micron (MU 54.65, -0.47, -0.9%): during its presentation at Wells Fargo TMT Summit: "Pricing has trended well below what we thought it would be when we had our earnings call [on September 29]"
Boeing (BA 177.75, +2.25, +1.3%): Lawmakers close to compromise on Boeing 737 Max certification, according to Bloomberg.
AI
